Abstract

Heart transplantation is currently the preferred treatment for patients with end stage heart failure, with a median survival rate of 11 years for all patients and 14 years for patients who survive the early post-implantation period [1]. A limited number of donor organs andmorepeople livingwith serious heart failure have increasedtheimportance for alternative options. Ventricular assist devices are being successfully used as bridge-to-transplant or as destination therapy when heart transplantation cannot be considered, for example due to inoperability or non-compliance. Implantation of a VAD has shown to improve exercise capacity, quality of life and mortality in patients with severe heart failure, although exercise capacity after VAD therapy remainsbelow that reportedfor age-matchedcontrolsafter heart transplantation [2]. Exercise and improved peak oxygen uptake (VO2peak) are related to improved quality of life and prognosis in patients with severe heart failure [3]. Therefore, improving VO2 peak is an important goal with multifaceted clinical relevance in patients on VAD therapy. The few studies investigating exercise in patients on VAD therapy

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.